# Category Lead Oncology & Rare Disease - Middle East at Pfizer

Pfizer is hiring a Category Lead Oncology & Rare Disease - Middle East in Dubai, United Arab Emirates. Level rates it Little AI ●○○○; you can [apply on Pfizer](https://jobsbylevel.com/go/de050bb4-3e77-46e7-8759-25966776c411?utm_medium=ai-agent).

AI Level 1, AI centrality 37 out of 100. United Arab Emirates - Dubai.

## Details

- Company: [Pfizer](https://jobsbylevel.com/companies/pfizer)
- AI level: AI Level 1 (score 37 out of 100)
- Location: United Arab Emirates - Dubai
- Posted: October 20, 2026
- Apply: https://jobsbylevel.com/go/de050bb4-3e77-46e7-8759-25966776c411?utm_medium=ai-agent

## Description

ROLE SUMMARY The Category Lead, Oncology & Rare Disease – Middle East is a strategic member of the Middle East Leadership Team, accountable for the portfolio’s end-to-end strategy, performance and long-term value across the cluster. The role translates enterprise and regional priorities into differentiated portfolio, launch and market strategies that balance near-term performance with sustainable growth and patient impact. It sets clear priorities across in-line brands, Growth Knots and breakthrough launches, enabling disciplined investment, resource allocation and execution across diverse Middle East healthcare systems. Working across Commercial, Medical, Access & Value, Regulatory, Policy & Public Affairs, Supply, Finance, Legal and Compliance—as well as regional and global teams—the role creates the conditions for launch excellence, expanded patient access and sustainable portfolio growth. It also builds a high-performing marketing organization and strengthens category leadership, customer engagement and execution capabilities across the cluster. CORE ACCOUNTABILITIES 1. CATEGORY STRATEGY & PORTFOLIO LEADERSHIP Translate the Middle East Oncology and Rare Disease strategy into clear portfolio, brand, market and customer priorities aligned with the cluster operating plan and growth agenda. Lead end-to-end portfolio planning across in-line brands, new indications, pipeline assets and future launches, balancing current performance with long-term category value. Shape differentiated strategies that reflect local disease burden, clinical pathways, diagnostic requirements, patient needs, access conditions and competitive dynamics. Establish category governance, operating rhythms and performance reviews that connect enterprise and regional strategy with market execution. Make disciplined portfolio trade-offs and direct resources toward the highest-value opportunities for patients and the business. 2. BUSINESS & P&L LEADERSHIP Own category performance, providing clear direction on revenue, profitability, market share, investment and resource deployment. Lead annual operating and long-range planning for the Oncology and Rare Disease portfolio, ensuring robust assumptions, scenarios, risk assessment and growth choices. Prioritize approved marketing and commercial investments across brands, launches and markets, reallocating resources to the highest-impact opportunities. Monitor performance and intervene early when launch, demand, access, supply or execution risks threaten category objectives. Use performance data, market intelligence and customer insights to accelerate decisions and strengthen execution. 3. LAUNCH & LIFECYCLE EXCELLENCE Lead integrated launch strategy and readiness for new products, indications and presentations across Middle East markets. Define launch ambition, sequencing, market archetypes, customer strategy, investment requirements and critical success factors. Build integrated launch plans across Regulatory, Medical, Access & Value, Policy & Public Affairs, Supply, Marketing, Sales and customer engagement. Track readiness and post-launch performance through clear milestones and governance, accelerating decisions and removing execution barriers. Optimize lifecycle strategies for in-line assets to sustain growth, expand patient reach and maximize portfolio value. 4. PATIENT JOURNEY, DIAGNOSTICS & ECOSYSTEM DEVELOPMENT Identify barriers across awareness, diagnosis, referral, treatment initiation, monitoring and continuity of care. Translate patient and healthcare-system insights into compliant, cross-functional priorities and solutions. Sponsor initiatives that strengthen diagnostic pathways, specialist networks and coordinated care. Ensure category strategies reflect the needs of patients, caregivers, healthcare professionals and health-system stakeholders. Define measurable outcomes for priority patient-journey and ecosystem initiatives. 5. MARKET SHAPING & PATIENT ACCESS Partner with Access & Value, Medical,

The description is cut here. Read the full offer: https://jobsbylevel.com/jobs/category-lead-oncology-rare-disease-middle-east-at-pfizer-c17ec2

Source: https://jobsbylevel.com/jobs/category-lead-oncology-rare-disease-middle-east-at-pfizer-c17ec2

## Cite this page

Level. https://jobsbylevel.com/jobs/category-lead-oncology-rare-disease-middle-east-at-pfizer-c17ec2.

Get job alerts: https://jobsbylevel.com/newsletter